Back to search

VACCINES AS TREATMENT STRATEGIES FOR RELAPSED PROSTATE CANCER

Data up to Jan 2025

Published2001
Citations20
References48

Total Citations Per Year

Abstract

References (48)

The Dendritic Cell System and its Role in Immunogenicity

1991 • 4,733 citations

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

1993 • 2,828 citations

The Central Role of CD4+ T Cells in the Antitumor Immune Response

1998 • 1,332 citations

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

1996 • 849 citations

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

1994 • 534 citations

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

1999 • 468 citations

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

1990 • 414 citations

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1996 • 398 citations

CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma

1998 • 375 citations

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo

1994 • 300 citations

Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

1997 • 292 citations

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

1997 • 279 citations

Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

1999 • 253 citations

Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

1983 • 230 citations

Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy

1994 • 210 citations

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.

1995 • 207 citations

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

1999 • 191 citations

Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.

1998 • 184 citations

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes.

1994 • 184 citations

Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.

1994 • 181 citations

GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.

1994 • 181 citations

Expression of Heterologous Sequences in Adenoviral Vectors

1992 • 171 citations

Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.

1991 • 132 citations

Cellular Mucins: Targets for Immunotherapy

2017 • 130 citations

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

1996 • 120 citations

Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines

1998 • 118 citations

High efficiency gene transfer into primary human tumor explants without cell selection.

1993 • 116 citations

Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

1996 • 112 citations

Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells.

1983 • 103 citations

Cellular Mucins: Targets for Immunotherapy

1994 • 102 citations

Total Synthesis of a Human Breast Tumor Associated Antigen

1995 • 100 citations

Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.

1995 • 95 citations

A Fully Synthetic Globo H Carbohydrate Vaccine Induces a Focused Humoral Response in Prostate Cancer Patients: A Proof of Principle

1999 • 88 citations

Immunization of Mice with a Fully Synthetic Globo H Antigen Results in Antibodies against Human Cancer Cells: A Combined Chemical—Immunological Approach to the Fashioning of an Anticancer Vaccine

1997 • 86 citations

Rapid transgene expression in lymphocyte and macrophage primary cultures after particle bombardment-mediated gene transfer

1993 • 84 citations

Immunologic approaches to the treatment of prostate cancer.

1999 • 83 citations

Application of the Glycal Assembly Method to the Concise Synthesis of Neoglycoconjugates of Ley and Leb Blood Group Determinants and of H-Type I and H-Type II Oligosaccharides

1995 • 71 citations

Gene Transfer into Mammalian Cells by Particle Bombardment

1994 • 52 citations

Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene

1990 • 41 citations

Analysis of human tumor associated Thomsen-Friedenreich antigen.

1990 • 39 citations

Regression of Established Mouse Leukemia by GM-CSF-Transduced Tumor Vaccine: Implications for Cytotoxic T Lymphocyte Responses and Tumor Burdens

1997 • 37 citations

Generation of allo-reactive cytotoxic T lymphocytes by particle bombardment-mediated gene transfer

1994 • 31 citations

Gene therapy: principles and potential.

1995 • 22 citations

Gene therapy for prostate cancer.

1996 • 20 citations

Targeted therapy for prostate cancer: the Memorial Sloan-Kettering Cancer Center approach.

1996 • 19 citations

Gene therapy for human prostate cancer. Translational research in the hormone refractory dunning prostate cancer model

1995 • 14 citations

Gene Therapy Approaches in Urologic Oncology

1995 • 10 citations

The Current Status of Gene Therapy for Prostate Cancer

1998 • 7 citations

Cited By (0)

No citing papers found in database

VACCINES AS TREATMENT STRATEGIES FOR RELAPSED PROSTATE CANCER (2001) – Hematology/Oncology Clinics of North America | Metascience Observatory Explorer